KEGG   PATHWAY: oro04930
Entry
oro04930                    Pathway                                
Name
Type II diabetes mellitus - Odobenus rosmarus divergens (Pacific walrus)
Description
Insulin resistance is strongly associated with type II diabetes. "Diabetogenic" factors including FFA, TNFalpha and cellular stress induce insulin resistance through inhibition of IRS1 functions. Serine/threonine phosphorylation, interaction with SOCS, regulation of the expression, modification of the cellular localization, and degradation represent the molecular mechanisms stimulated by them. Various kinases (ERK, JNK, IKKbeta, PKCzeta, PKCtheta and mTOR) are involved in this process.
The development of type II diabetes requires impaired beta-cell function. Chronic hyperglycemia has been shown to induce multiple defects in beta-cells. Hyperglycemia has been proposed to lead to large amounts of reactive oxygen species (ROS) in beta-cells, with subsequent damage to cellular components including PDX-1. Loss of PDX-1, a critical regulator of insulin promoter activity, has also been proposed as an important mechanism leading to beta-cell dysfunction.
Although there is little doubt as to the importance of genetic factors in type II diabetes, genetic analysis is difficult due to complex interaction among multiple susceptibility genes and between genetic and environmental factors. Genetic studies have therefore given very diverse results. Kir6.2 and IRS are two of the candidate genes. It is known that Kir6.2 and IRS play central roles in insulin secretion and insulin signal transmission, respectively.
Class
Human Diseases; Endocrine and metabolic disease
Pathway map
oro04930  Type II diabetes mellitus
oro04930

Organism
Odobenus rosmarus divergens (Pacific walrus) [GN:oro]
Gene
101383590  INS; insulin [KO:K04526]
101363371  INSR; insulin receptor isoform X1 [KO:K04527] [EC:2.7.10.1]
101367978  IRS1; insulin receptor substrate 1 [KO:K16172]
101381397  IRS2; insulin receptor substrate 2 [KO:K07187]
101378833  insulin receptor substrate 2-like [KO:K17445]
101371781  IRS4; LOW QUALITY PROTEIN: insulin receptor substrate 4 [KO:K17446]
101374787  PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma [KO:K02649]
101370100  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
101371800  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
101370689  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
101385241  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
101385267  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [KO:K00922] [EC:2.7.1.153]
101373530  SLC2A4; solute carrier family 2, facilitated glucose transporter member 4 [KO:K07191]
101377069  ADIPOQ; adiponectin isoform X1 [KO:K07296]
101372573  MAPK1; mitogen-activated protein kinase 1 isoform X1 [KO:K04371] [EC:2.7.11.24]
101382213  MAPK3; mitogen-activated protein kinase 3 isoform X1 [KO:K04371] [EC:2.7.11.24]
101363844  MTOR; LOW QUALITY PROTEIN: serine/threonine-protein kinase mTOR [KO:K07203] [EC:2.7.11.1]
101380706  PRKCZ; protein kinase C zeta type [KO:K18952] [EC:2.7.11.13]
101376722  SOCS1; suppressor of cytokine signaling 1 [KO:K04694]
101373719  SOCS2; LOW QUALITY PROTEIN: suppressor of cytokine signaling 2 [KO:K04695]
101364487  SOCS3; suppressor of cytokine signaling 3 [KO:K04696]
101383881  SOCS4; suppressor of cytokine signaling 4 [KO:K04697]
101375346  IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta isoform X1 [KO:K07209] [EC:2.7.11.10]
101367488  MAPK10; mitogen-activated protein kinase 10 isoform X1 [KO:K04440] [EC:2.7.11.24]
101374143  MAPK8; mitogen-activated protein kinase 8 isoform X3 [KO:K04440] [EC:2.7.11.24]
101376185  MAPK9; mitogen-activated protein kinase 9 isoform X2 [KO:K04440] [EC:2.7.11.24]
101368209  TNF; tumor necrosis factor [KO:K03156]
101385728  PRKCD; protein kinase C delta type isoform X2 [KO:K06068] [EC:2.7.11.13]
101362539  PRKCE; protein kinase C epsilon type [KO:K18050] [EC:2.7.11.13]
101382101  PDX1; pancreas/duodenum homeobox protein 1 [KO:K07594]
101383866  MAFA; transcription factor MafA [KO:K07595]
101367009  SLC2A2; solute carrier family 2, facilitated glucose transporter member 2 isoform X1 [KO:K07593]
101373969  HK1; hexokinase-1 isoform X2 [KO:K00844] [EC:2.7.1.1]
101374267  HKDC1; putative hexokinase HKDC1 [KO:K00844] [EC:2.7.1.1]
101383196  HK3; hexokinase-3 [KO:K00844] [EC:2.7.1.1]
101384043  HK2; hexokinase-2 [KO:K00844] [EC:2.7.1.1]
101383256  GCK; glucokinase [KO:K12407] [EC:2.7.1.2]
101382111  PKM; pyruvate kinase PKM isoform X2 [KO:K00873] [EC:2.7.1.40]
101364399  PKLR; pyruvate kinase PKLR [KO:K12406] [EC:2.7.1.40]
101366830  KCNJ11; ATP-sensitive inward rectifier potassium channel 11 [KO:K05004]
101366537  ABCC8; ATP-binding cassette sub-family C member 8 isoform X2 [KO:K05032]
101365624  CACNA1C; voltage-dependent L-type calcium channel subunit alpha-1C isoform X1 [KO:K04850]
101383514  CACNA1D; voltage-dependent L-type calcium channel subunit alpha-1D isoform X1 [KO:K04851]
101378448  CACNA1A; voltage-dependent P/Q-type calcium channel subunit alpha-1A isoform X1 [KO:K04344]
105758129  voltage-dependent N-type calcium channel subunit alpha-1B-like [KO:K04849]
101364776  CACNA1E; voltage-dependent R-type calcium channel subunit alpha-1E [KO:K04852]
101372746  CACNA1G; voltage-dependent T-type calcium channel subunit alpha-1G isoform X1 [KO:K04854]
Compound
C00002  ATP
C00022  Pyruvate
C00031  D-Glucose
C00076  Calcium cation
C00162  Fatty acid
C00238  Potassium cation
Reference
  Authors
Stumvoll M, Goldstein BJ, van Haeften TW.
  Title
Type 2 diabetes: principles of pathogenesis and therapy.
  Journal
Lancet 365:1333-46 (2005)
DOI:10.1016/S0140-6736(05)61032-X
Reference
  Authors
Gual P, Le Marchand-Brustel Y, Tanti JF.
  Title
Positive and negative regulation of insulin signaling through IRS-1 phosphorylation.
  Journal
Biochimie 87:99-109 (2005)
DOI:10.1016/j.biochi.2004.10.019
Reference
  Authors
Henquin JC.
  Title
Triggering and amplifying pathways of regulation of insulin secretion by glucose.
  Journal
Diabetes 49:1751-60 (2000)
DOI:10.2337/diabetes.49.11.1751
Reference
  Authors
Chandra J, Zhivotovsky B, Zaitsev S, Juntti-Berggren L, Berggren PO, Orrenius S.
  Title
Role of apoptosis in pancreatic beta-cell death in diabetes.
  Journal
Diabetes 50 Suppl 1:S44-7 (2001)
DOI:10.2337/diabetes.50.2007.S44
Reference
  Authors
Kaneto H, Matsuoka TA, Nakatani Y, Kawamori D, Miyatsuka T, Matsuhisa M, Yamasaki Y.
  Title
Oxidative stress, ER stress, and the JNK pathway in type 2 diabetes.
  Journal
J Mol Med 83:429-39 (2005)
DOI:10.1007/s00109-005-0640-x
Reference
  Authors
Sakai K, Matsumoto K, Nishikawa T, Suefuji M, Nakamaru K, Hirashima Y, Kawashima J, Shirotani T, Ichinose K, Brownlee M, Araki E.
  Title
Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic beta-cells.
  Journal
Biochem Biophys Res Commun 300:216-22 (2003)
DOI:10.1016/S0006-291X(02)02832-2
Reference
  Authors
Kaneto H, Xu G, Song KH, Suzuma K, Bonner-Weir S, Sharma A, Weir GC.
  Title
Activation of the hexosamine pathway leads to deterioration of pancreatic beta-cell function through the induction of oxidative stress.
  Journal
J Biol Chem 276:31099-104 (2001)
DOI:10.1074/jbc.M104115200
Reference
PMID:9011569
  Authors
Matsuoka T, Kajimoto Y, Watada H, Kaneto H, Kishimoto M, Umayahara Y, Fujitani Y, Kamada T, Kawamori R, Yamasaki Y.
  Title
Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells.
  Journal
J Clin Invest 99:144-50 (1997)
DOI:10.1172/JCI119126
Reference
PMID:7491105
  Authors
Sharma A, Olson LK, Robertson RP, Stein R.
  Title
The reduction of insulin gene transcription in HIT-T15 beta cells chronically exposed to high glucose concentration is associated with the loss of RIPE3b1 and STF-1 transcription factor expression.
  Journal
Mol Endocrinol 9:1127-34 (1995)
DOI:10.1210/mend.9.9.7491105
Reference
  Authors
Robertson RP.
  Title
Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes.
  Journal
J Biol Chem 279:42351-4 (2004)
DOI:10.1074/jbc.R400019200
Reference
PMID:9974390
  Authors
Eto K, Tsubamoto Y, Terauchi Y, Sugiyama T, Kishimoto T, Takahashi N, Yamauchi N, Kubota N, Murayama S, Aizawa T, Akanuma Y, Aizawa S, Kasai H, Yazaki Y, Kadowaki T.
  Title
Role of NADH shuttle system in glucose-induced activation of mitochondrial metabolism and insulin secretion.
  Journal
Science 283:981-5 (1999)
DOI:10.1126/science.283.5404.981
Reference
  Authors
Novelli M, Fabregat ME, Fernandez-Alvarez J, Gomis R, Masiello P.
  Title
Metabolic and functional studies on isolated islets in a new rat model of type 2 diabetes.
  Journal
Mol Cell Endocrinol 175:57-66 (2001)
DOI:10.1016/S0303-7207(01)00400-2
Reference
  Authors
Yang SN, Berggren PO.
  Title
Beta-cell CaV channel regulation in physiology and pathophysiology.
  Journal
Am J Physiol Endocrinol Metab 288:E16-28 (2005)
DOI:10.1152/ajpendo.00042.2004
Related
pathway
oro04210  Apoptosis
oro04910  Insulin signaling pathway
oro04920  Adipocytokine signaling pathway
oro04950  Maturity onset diabetes of the young
KO pathway
ko04930   
LinkDB

DBGET integrated database retrieval system